Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001177 · ClinicalTrials.gov registry record
Study of Premenstrual Syndrome and Premenstrual Dysphoria
A clinical trial of Mood Disorder, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- 1,600
- Enrollment target
- 1
- Study location
NCT00001177: Recruiting study of Mood Disorder, sponsored by National Institute of Mental Health (NIMH).
NCT00001177 is a study of Mood Disorder that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,600 participants, above the 1,079-participant average among 7 other Mood Disorder trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001177, a study of Mood Disorder, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- 1,600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and describe the symptoms of premenstrual syndrome (PMS). Women who experience PMS symptoms will complete clinical interviews, self-rating scales, and evaluations of mood and endocrine function. A subgroup of women with severe PMS (Premenstrual Dysphoric Disorder or PMDD) will be offered additional research studies that focus on: 1) identifying the endocrine changes that may be responsible for changes in mood and behavior during the premenstrual period, 2) evaluating treatments for PMS symptoms, and/or 3) identifying genetic factors in women with and without PMS. Women with recurrent brief depression will also be recruited to serve as a comparison group....
Primary Outcome
Standardized cross-sectional rating scales (Beck Depression Inventory, Hamilton Depression and Anxiety Scales, and the Rating Scale for Premenstrual Tension Syndrome), symptom rating scales completed daily, and plasma hormone measures (including neurosteroid levels).
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 1984-03-09 |
What NCT00001177 shows while recruiting
NCT00001177 is an observational study that tracks outcomes without assigning an intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,079-participant average among 7 other Mood Disorder trials with a reported enrollment target (48% higher).
The record links to 1 condition, with Mood Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00001177 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001177 about?
NCT00001177 is a clinical study titled "Study of Premenstrual Syndrome and Premenstrual Dysphoria". The purpose of this study is to identify and describe the symptoms of premenstrual syndrome (PMS). Women who experience PMS symptoms will complete clinical interviews, self-rating scales, and evaluations of mood and endocrine function. A subgroup of women with severe PMS (Premenstrual Dysphoric Dis...
What is the current status of trial NCT00001177?
This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 1984-03-09.
What conditions does trial NCT00001177 study?
This clinical trial studies the following conditions: Mood Disorder.
Who is sponsoring clinical trial NCT00001177?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001177 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
RECRUITING
-
Adolescence, Puberty, and Emotion Regulation
COMPLETED
-
Perimenopause-Related Mood and Behavioral Disorders
COMPLETED
-
Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers
COMPLETED
-
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
COMPLETED · Phase 2
-
Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI